Best Options Strategy for ARVN
Looking for the best options strategy for Arvinas, Inc. (ARVN)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live ARVN option chain right now, and a simple map from your view on ARVN to the strategy that fits it. Model any of them in the calculator before you trade.
About ARVN
Arvinas, Inc. (ARVN) is a major company in Biotechnology. Options traders on ARVN tend to watch , since these can drive large moves in the share price.
About Arvinas, Inc.
Arvinas is a biotechnology company focused on discovering and developing drugs that eliminate disease-causing proteins from the body. The company's core technology platform centers on PROTACs—proteolysis targeting chimeras—which work by hijacking the body's natural protein disposal machinery to degrade and remove specific proteins associated with disease. The company has built a pipeline of candidates across multiple therapeutic areas. In oncology, it is pursuing treatments for cancers driven by specific mutations, including a G12D KRAS inhibitor for pancreatic, colorectal, and lung cancers, as well as a therapy targeting B-cell lymphoma 6 protein for relapsed or refractory non-Hodgkin lymphoma and an estrogen receptor degrader for hormone receptor-positive breast cancer. Beyond cancer, the company is developing treatments for neurodegenerative disease and other protein-driven conditions. Several of its programs have progressed into human clinical testing.
Arvinas generates value through partnering arrangements with established pharmaceutical companies including Pfizer, Genentech, Roche, and Bayer, which provide funding and development support for specific programs. As a…
Today's top-scoring strategy for ARVN
Our engine ranks defined-risk strategies on the live ARVN chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Sell | 1× | CALL | $10 | $0.06 |
| Buy | 1× | CALL | $11 | $0.01 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $11 | −$75 | −$71 | −$67 | −$64 | −$62 |
| $11 | −$57 | −$54 | −$53 | −$51 | −$50 |
| $10 | −$34 | −$35 | −$36 | −$37 | −$37 |
| $10 | −$14 | −$18 | −$21 | −$23 | −$25 |
| $9 | −$2 | −$5 | −$9 | −$11 | −$14 |
| $9 | $3 | $2 | −$1 | −$3 | −$5 |
| $9 | $5 | $4 | $3 | $2 | −$0 |
| $8 | $5 | $5 | $5 | $4 | $3 |
| $8 | $5 | $5 | $5 | $5 | $4 |
| $7 | $5 | $5 | $5 | $5 | $5 |
| $7 | $5 | $5 | $5 | $5 | $5 |
Illustrative example at ARVN's latest available price, computed with the same engine as the tool. Live option fills and the real IV skew refresh during US market hours.
Implied volatility
ARVN is currently trading with moderate implied volatility, broadly in line with other large-cap stocks. On the options we scanned that was around 32% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on ARVN currently price in about 32% implied volatility, versus roughly 47% the stock has actually realised over the past month. That makes options relatively cheap — an edge for strategies that buy premium, such as long calls, long puts and debit spreads.
Off that volatility, the options market is pricing a move of about ±$0.89 (±10%) in ARVN by 2026-09-18 — a range of roughly $8.07 to $9.86. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, downside puts on ARVN trade at a higher implied volatility than upside calls — the market is paying up for crash protection. That skew favours selling put spreads or buying calls over symmetric trades.
ARVN insider trading activity (SEC Form 4)
Open-market insider transactions at ARVN over roughly the last six months, from SEC Form 4 filings. Open-market buys are the rarer, more telling signal — routine selling under pre-arranged plans is common, so read a net-selling figure with that in mind.
| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| Saik Andrew | Sell | 5,696 | $46K | 2026-06-24 |
| Cacace Angela M | Sell | 2,576 | $20K | 2026-06-17 |
| Teel Randy | Sell | 2,209 | $20K | 2026-05-21 |
| Loomis David K | Sell | 1,919 | $19K | 2026-05-11 |
| Cacace Angela M | Sell | 9,657 | $96K | 2026-05-11 |
| Teel Randy | Sell | 9,657 | $96K | 2026-05-11 |
Source: SEC Form 4 filings via Finnhub. Open-market purchases (P) and sales (S) only — grants, option exercises, gifts and tax withholding are excluded. Informational context, not investment advice.
Earnings & IV crush
ARVN's next earnings report is due around November 4, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Key figures
- Market cap
- $554M
- 52-week range
- $6.06–$14.51 (34% up the range)
- Short interest
- 7.2% of float · 5.2 days to cover
How to choose an options strategy for ARVN
Start with your outlook on ARVN, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while ARVN stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open ARVN in the free calculator →
Frequently asked questions
What is the best options strategy for ARVN?
It depends on your outlook. Bullish traders often use a long call or bull call spread on ARVN; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are ARVN options liquid enough to trade?
Arvinas, Inc. (ARVN) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade ARVN options?
Buying a single ARVN call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade ARVN or any security. Do your own research.
What does Arvinas, Inc. do?
Arvinas, Inc. (ARVN) operates in the Biotechnology industry. The "About Arvinas, Inc." section above gives a fuller picture of what the company does and how it earns money.
Does Arvinas, Inc. pay a dividend?
We don't show a confirmed dividend yield for Arvinas, Inc. here, so treat it as uncertain: before writing calls, check its current dividend and ex-dividend date with your broker — an approaching ex-dividend date can trigger early assignment on in-the-money short calls.
When does Arvinas, Inc. next report earnings?
Arvinas, Inc.'s next earnings are expected around November 4, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Tickers related to ARVN
Comparing ARVN with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 5 Science Park, 395 Winchester Avenue, New Haven, CT, 06511, United States
- Industry
- Biotechnology
- Employees
- 246
- CEO
- Dr. Randy Teel Ph.D.
- Phone
- 203 535 1456
- Website
- www.arvinas.com
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.